Celcis shares drop after profits warning
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Shares in Celsis International, the biotech company founded by the scientist Chris Evans and chaired by former England rugby coach Jack Rowell, lost 27 per cent of their value yesterday after the company issued a profits warning. The shares slumped 19p to a record low of 51.5p when the company said adverse currency factors and the financial turmoil in Asia meant current year profits were unlikely to meet analysts forecasts of pounds 1m-pounds 3m. The shares are now barely half the 100p issue price when the group came to the market in 1993.
The announcement was pounced upon by bear raider Simon Cawkwell who been selling the shares "in the high 70s [pence]" the previous day. Mr Cawkwell, who is known in the market as "Evil Knievel", bought some shares back yesterday as the price fell sharply. However, he said that the company still faced difficulties. "It looks to me as if they have lost their way."
Some analysts questioned whether the profits alert would lead to management changes. But Arthur Holden, Celsis' chief executive, said no decisions had been taken. "The company will review the situation after the dust has settled and take the appropriate action." Founder Chris Evans is a non-executive director of the group. Separately the company said it had unified the distribution of its hygiene monitoring product line SystemSURE, by granting its US distributor Becton Dickinson exclusive rights worldwide. This has delayed short-term products sales for markets outside the US. But the company said it believed the new arrangement would provide a more efficient long-term solution.
In its statement, Celsis added that it was "developing a number of important new product initiatives for exploiting its proprietary technology and remains confident about the prospects for continued growth."
Celsis makes hygiene monitoring kits which detect contamination in food.
In October, the company raised pounds 3.7m through the placing of new shares at 95p. The cash was raised to help fund the pounds 4.4m purchase of Scientific Associates, a contract testing centre in the US.
Celsis shares reached a peak of 141.5p in 1995.
Subscribe to Independent Premium to bookmark this article
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments